Elisa Nada

1.0k total citations
23 papers, 436 citations indexed

About

Elisa Nada is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Epidemiology. According to data from OpenAlex, Elisa Nada has authored 23 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Elisa Nada's work include Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes Management and Research (5 papers). Elisa Nada is often cited by papers focused on Diabetes Treatment and Management (10 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes Management and Research (5 papers). Elisa Nada collaborates with scholars based in Italy, United States and Egypt. Elisa Nada's co-authors include Carlo Giorda, Barbara Tartaglino, Giovanni Corona, Piero Guida, Domenico Cucinotta, Roberto Gnavi, Lisa Marafetti, Roberta Picariello, Giuseppe Costa and Carlotta Sacerdote and has published in prestigious journals such as PLoS ONE, The Lancet Diabetes & Endocrinology and Diabetes Obesity and Metabolism.

In The Last Decade

Elisa Nada

23 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Nada Italy 9 342 129 106 87 75 23 436
Giovanni La Croce Italy 14 93 0.3× 87 0.7× 189 1.8× 66 0.8× 29 0.4× 50 515
Richele Bettencourt United States 9 280 0.8× 229 1.8× 35 0.3× 66 0.8× 201 2.7× 16 503
Payam Hakimian United States 6 79 0.2× 34 0.3× 51 0.5× 99 1.1× 58 0.8× 9 325
Sarah Cipriani Italy 8 136 0.4× 107 0.8× 29 0.3× 35 0.4× 18 0.2× 14 333
Mauro Dicuio Italy 10 145 0.4× 66 0.5× 28 0.3× 39 0.4× 30 0.4× 22 357
Zeki Bayraktar Türkiye 11 54 0.2× 57 0.4× 68 0.6× 49 0.6× 69 0.9× 32 387
Lucio Varanese United Kingdom 9 334 1.0× 474 3.7× 36 0.3× 21 0.2× 23 0.3× 13 581
Hisanori Taniguchi Japan 11 79 0.2× 85 0.7× 99 0.9× 90 1.0× 4 0.1× 65 409
Stefan Sultana United Kingdom 11 57 0.2× 103 0.8× 88 0.8× 25 0.3× 18 0.2× 19 291
Fuat Kızılay Türkiye 9 52 0.2× 63 0.5× 63 0.6× 50 0.6× 13 0.2× 57 331

Countries citing papers authored by Elisa Nada

Since Specialization
Citations

This map shows the geographic impact of Elisa Nada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Nada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Nada more than expected).

Fields of papers citing papers by Elisa Nada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Nada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Nada. The network helps show where Elisa Nada may publish in the future.

Co-authorship network of co-authors of Elisa Nada

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Nada. A scholar is included among the top collaborators of Elisa Nada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Nada. Elisa Nada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nada, Elisa, et al.. (2025). Effect of adding fenofibrate versus curcumin to glimepiride in patients with type 2 diabetes: a randomized controlled trial. BMC Pharmacology and Toxicology. 26(1). 119–119. 2 indexed citations
2.
Giorda, Carlo, Roberta Picariello, Barbara Tartaglino, et al.. (2024). Hospitalisation for herpes zoster in people with and without diabetes: A 10-year-observational study. Diabetes Research and Clinical Practice. 210. 111603–111603. 4 indexed citations
3.
Curi, Rui, Stefano Gazzina, Barbara Tartaglino, et al.. (2024). Diabetic retinopathy screening with confocal fundus camera and artificial intelligence - assisted grading. European Journal of Ophthalmology. 35(2). 679–688. 1 indexed citations
4.
Piatti, Alessandra, Francesco Romeo, Roberta Manti, et al.. (2023). Feasibility and accuracy of the screening for diabetic retinopathy using a fundus camera and an artificial intelligence pre-evaluation application. Acta Diabetologica. 61(1). 63–68. 4 indexed citations
5.
Giorda, Carlo, Roberta Picariello, Barbara Tartaglino, et al.. (2023). Hepatocellular carcinoma in a large cohort of type 2 diabetes patients. Diabetes Research and Clinical Practice. 200. 110684–110684. 3 indexed citations
6.
Giorda, Carlo, Roberta Picariello, Barbara Tartaglino, et al.. (2022). Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic. Acta Diabetologica. 59(6). 861–864. 2 indexed citations
7.
Giorda, Carlo, Roberta Picariello, Barbara Tartaglino, et al.. (2021). Hepatic fibrosis of any origin in a large population of type 2 diabetes patients. Nutrition Metabolism and Cardiovascular Diseases. 31(10). 2887–2894. 4 indexed citations
8.
Giorda, Carlo, Roberta Picariello, Barbara Tartaglino, et al.. (2021). From swab testing to health outcomes within the T2DM population: Impact of diabetes background on COVID19 progression. Diabetes Research and Clinical Practice. 180. 109021–109021. 7 indexed citations
9.
Cioffi, Giovanni, Carlo Giorda, Donata Lucci, et al.. (2020). Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trial. European Journal of Preventive Cardiology. 28(1). 8–17. 6 indexed citations
10.
Giorda, Carlo, Roberta Picariello, Barbara Tartaglino, et al.. (2019). Incretin-based therapy and risk of cholangiocarcinoma: a nested case–control study in a population of subjects with type 2 diabetes. Acta Diabetologica. 57(4). 401–408. 8 indexed citations
11.
12.
Corona, Giovanni, et al.. (2016). Sexual Dysfunction in Type 2 Diabetes at Diagnosis: Progression over Time and Drug and Non-Drug Correlated Factors. PLoS ONE. 11(10). e0157915–e0157915. 27 indexed citations
13.
14.
Giorda, Carlo, Roberta Picariello, Elisa Nada, et al.. (2014). Comparison of direct costs of type 2 diabetes care: Different care models with different outcomes. Nutrition Metabolism and Cardiovascular Diseases. 24(7). 717–724. 11 indexed citations
15.
Giorda, Carlo, Carlotta Sacerdote, Elisa Nada, et al.. (2014). Incretin-based therapies and acute pancreatitis risk: a systematic review and meta-analysis of observational studies. Endocrine. 48(2). 461–471. 53 indexed citations
16.
17.
Giorda, Carlo, Roberta Picariello, Elisa Nada, et al.. (2013). Incretin therapies and risk of hospital admission for acute pancreatitis in an unselected population of European patients with type 2 diabetes: a case-control study. The Lancet Diabetes & Endocrinology. 2(2). 111–115. 34 indexed citations
18.
Corona, Giovanni, et al.. (2013). The SUBITO-DE study: sexual dysfunction in newly diagnosed type 2 diabetes male patients.. PubMed. 36(10). 864–8. 43 indexed citations
19.
Giorda, Carlo, Roberta Picariello, Elisa Nada, et al.. (2012). The Impact of Adherence to Screening Guidelines and of Diabetes Clinics Referral on Morbidity and Mortality in Diabetes. PLoS ONE. 7(4). e33839–e33839. 45 indexed citations
20.
Giorda, Carlo, Michela Mulas, Valeria Manicardi, et al.. (2012). Factors associated with a rapid normalization of HbA1c in newly diagnosed type 2 diabetes patients seen in a specialist setting. Acta Diabetologica. 50(1). 81–87. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giovanni La Croce Breakdown of academic impact, for papers by Richele Bettencourt Breakdown of academic impact, for papers by Payam Hakimian Breakdown of academic impact, for papers by Sarah Cipriani Breakdown of academic impact, for papers by Mauro Dicuio Breakdown of academic impact, for papers by Zeki Bayraktar Breakdown of academic impact, for papers by Lucio Varanese Breakdown of academic impact, for papers by Hisanori Taniguchi Breakdown of academic impact, for papers by Stefan Sultana Breakdown of academic impact, for papers by Fuat Kızılay
Rankless by CCL
2026